The late complications of diabetes mellitus
- PMID: 1742148
The late complications of diabetes mellitus
Abstract
Late complications of diabetes mellitus include a variety of clinical pictures, mainly related to the involvement of the arterial wall both of large vessels (macroangiopathy) and small vessels (microangiopathy), and of the peripheral nervous system (neuropathy). Their presence in almost all types of diabetes indicates that there is a common pathogenetic mechanism, which can be substantially identified in high blood glucose levels and related alterations. Hyperglycemia, in fact, leads to some metabolic abnormalities, i.e. non-enzymatic glycosylation of proteins and polyol pathway activity; moreover it can negatively affect the pattern of some hormones, especially GH and sex steroids, and normal rheological and clotting properties of blood. These abnormalities, confirmed by experimental models, play a key role in the development of late diabetic complications. However some evidence indicates that a genetic background may predispose to their development or protect from their onset. The two main forms of diabetic retinopathy, non-proliferative and proliferative, show an incidence which increases with age and duration of diabetes, reaching 100% when diabetes lasts for more than 20 years. The risk of blindness, which is very high for the proliferative form, has been dramatically reduced by laser-photocoagulation. Diabetic nephropathy affects a lesser number of diabetics but, after a silent or preclinical stage, leads to renal failure and subsequent replacement therapy. Strict metabolic control in the silent stage and later rigid anti-hypertensive treatment can prevent or retard the evolution of this complication. A close association has been observed between diabetes and hypertension, which can directly affect the onset and evolution of diabetic nephropathy, probably through a common genetic mechanism. Diabetic neuropathy has a wide variety of clinical manifestations, at somatic, autonomic and central levels and can greatly modify the quality and expectancy of life. However, the major cause of death in diabetic subjects is large vessel disease or macroangiopathy, which is similar to non-diabetic atherosclerosis regarding the main histopathological and clinical manifestations but has a much higher prevalence and severity. Finally, a specific cardiomyopathy has also been described in diabetes mellitus and can account for the high rate of heart failure observed in these patients.
Similar articles
-
Diabetic microvascular complications: can patients at risk be identified? A review.Int J Clin Pract. 2006 Nov;60(11):1471-83. doi: 10.1111/j.1742-1241.2006.01175.x. Int J Clin Pract. 2006. PMID: 17073842 Review.
-
[Advanced microangiopathic complications at the diagnosis of diabetes mellitus].Orv Hetil. 2001 Aug 5;142(31):1687-90. Orv Hetil. 2001. PMID: 11556263 Hungarian.
-
Concomitant macro and microvascular complications in diabetic nephropathy.Saudi J Kidney Dis Transpl. 2009 May;20(3):402-9. Saudi J Kidney Dis Transpl. 2009. PMID: 19414942
-
[Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].Minerva Med. 2000 Jan-Feb;91(1-2):1-15. Minerva Med. 2000. PMID: 10858728 Clinical Trial. Italian.
-
Impact of hypertension on prognosis in IDDM.Diabete Metab. 1989;15(5 Pt 2):338-42. Diabete Metab. 1989. PMID: 2693153 Review.
Cited by
-
Associations between food insecurity and diabetes risk factors in US adolescents in the National Health and Nutrition Examination Survey (NHANES) 2007-2016.Public Health Nutr. 2024 Feb 12;27(1):e68. doi: 10.1017/S1368980024000284. Public Health Nutr. 2024. PMID: 38343166 Free PMC article.
-
Strength Training Prevents Hyperinsulinemia, Insulin Resistance, and Inflammation Independent of Weight Loss in Fructose-Fed Animals.Sci Rep. 2016 Aug 4;6:31106. doi: 10.1038/srep31106. Sci Rep. 2016. PMID: 27487746 Free PMC article.
-
Effect of fasting glucose levels on carotid intima-media thickness in premenopausal versus postmenopausal women.Arch Endocrinol Metab. 2024 Mar 7;68:e230110. doi: 10.20945/2359-4292-2023-0110. Arch Endocrinol Metab. 2024. PMID: 38456951 Free PMC article.
-
Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment.Diabetes Metab Syndr Obes. 2024 Jan 23;17:343-362. doi: 10.2147/DMSO.S421527. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38288338 Free PMC article. Review.
-
Survival outcomes for patients with surgically induced end-stage renal disease.Can Urol Assoc J. 2020 Mar;14(3):E65-E73. doi: 10.5489/cuaj.6010. Epub 2019 Sep 27. Can Urol Assoc J. 2020. PMID: 31599719 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical